All articles tagged: Urinary tract infection, site not specified (N39.0)
![]()
HealthDay
08 January at 11.36 PM
Acute Hospital Care at Home Shows Promise for Medically Complex PatientsA diverse group of medically complex patients receive acute hospital care at home (AHCaH), with low rates of mortality during hospitalization and at 30 days, according to a research letter published online Jan. 9 in the Annals of Internal Medicine.David M. Levine, M.D., M.P.H., from Brigham and Women's Hospital and Harvard Medical School |
![]()
HealthDay
08 January at 11.36 PM
Acute Hospital Care at Home Shows Promise for Medically Complex PatientsA diverse group of medically complex patients receive acute hospital care at home (AHCaH), with low rates of mortality during hospitalization and at 30 days, according to a research letter published online Jan. 9 in the Annals of Internal Medicine.David M. Levine, M.D., M.P.H., from Brigham and Women's Hospital and Harvard Medical School |
![]()
HealthDay
03 January at 04.36 PM
Incidence of Pediatric UTI Decreased in Early Pandemic PeriodThe incidence of pediatric urinary tract infection (UTI) decreased during the early prepandemic period, with no increase in disease severity, according to a study published online Jan. 3 in JAMA Network Open.Danni Liang, M.D., from the Stanford University School of Medicine in Palo Alto, California, and colleagues examined the populat |
![]()
HealthDay
02 January at 04.28 PM
Improvement Needed in Managing UTI in Patients With Neurogenic BladderExpansion of caregiver involvement, enhancement of patient-provider communication, and targeting providers and care settings that lack familiarity with neurogenic bladder (NB) could improve urinary tract infection (UTI) management in this population, according to a study published online Nov. 1 in PLOS ONE.Margaret A. Fitzpatrick, M.D., |
![]()
HealthDay
26 December at 05.01 PM
Five-Day Antibiotic Course Noninferior for Pediatric Febrile UTIFor young children with febrile urinary tract infection (fUTI), a five-day amoxicillin-clavulanate course is noninferior to a 10-day course for recurrence of UTI within 30 days after completion of therapy, according to a study published online Dec. 26 in Pediatrics.Giovanni Montini, M.D., from Ospedale Maggiore Policlinico in Milano, I |
![]()
HealthDay
05 December at 11.00 PM
Five Health Conditions Linked to Subsequent Diagnosis of MSFive health conditions are associated with subsequent diagnosis of multiple sclerosis, but they overlap with two other autoimmune diseases, according to a study published online Dec. 5 in Neurology.Octave Guinebretiere, from Sorbonne Université in Paris, and colleagues examined the association between diseases and symptoms diagnosed in |
![]()
HealthDay
04 December at 04.41 PM
Bladder Function Disorders Common in Refractory Nocturnal EnuresisChildren with refractory monosymptomatic (MNE) and nonmonosymptomatic (NMNE) primary nocturnal enuresis have considerable prevalence of bladder function disorders, according to a study published in the October issue of Health Science Reports.Farzaneh Sharifiaghdas, from the Shahid Beheshti University of Medical Sciences in Tehran, Iran, |
![]()
HealthDay
07 November at 11.50 PM
FDA Approves Voquezna for Erosive Esophagitis, GERDThe U.S. Food and Drug Administration has approved Voquezna (vonoprazan), a novel potassium-competitive acid blocker, as a new treatment for adults for with all grades of erosive esophagitis or erosive gastroesophageal reflux disease (GERD).The approval is based on the results of the PHALCON-EE phase 3 trial, in which Voquezna 20 mg met the prim |
![]()
HealthDay
03 November at 03.39 PM
Pediatric Neurogenic Bladder Cases Are Not Fully EvaluatedPediatric neurogenic bladder (NGB) cases are not fully evaluated in routine clinical practice, according to a study published online Oct. 16 in Advances in Therapy.Naoko Izumi, from Pfizer Japan in Tokyo, and colleagues conducted a retrospective cohort study involving patients aged 17 years and younger with NGB to examine the current sta |
![]()
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
![]()
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
![]()
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
![]()
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
![]()
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
![]()
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |